4.9 (526) In stock
A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.
New nanoparticles can perform gene editing in the lungs
CRISPR/Cas9-mediated gene editing. A promising strategy in
CRISPR-Cas9 base editors and their current role in human
Viral vectors and extracellular vesicles: innate delivery systems
Researchers reveal that new compact version of Cas7-11 enzyme
Tarek Fadel (@DrTarekFadel) / X
Nano Technology
Recent advances in the delivery and applications of nonviral
Lipid nanoparticle-based mRNA delivery systems for cancer
Can gene editing kill deadly diseases?, Features
Manuel C. en LinkedIn: New nanoparticles can perform gene editing
Lung SORT LNPs enable precise homology-directed repair mediated
Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled
New Nanoparticles Carrying mRNA Can Perform In-Lung Gene
New Inhalable Nanoparticles Perform Gene Editing Inside the Lungs
